Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"Continual reassessment method"”.

  1. Practical Extensions of the Continual Reassessment Method

    … studies using the likelihood-based time to event continual reassessment method (TITE-CRM). First, assuming group membership is known and the groups share some information regarding their maximum tolerated dose (MTD), we extend the two-group two-parameter CRM to the TITE-CRM. We examine the …

    uab Repository record for Practical Extensions of the Continual Reassessment Method (opens in a new tab)

  2. Application of the Continual Reassessment Method for Dose Finding Studies in Regional Anaesthesia

    … They consolidate the position of the modified Continual Reassessment Method as a reliable and robust methodology for future dose-finding studies in regional anaesthesia.

    whiterose Download PDF for Application of the Continual Reassessment Method for Dose Finding Studies in Regional Anaesthesia (opens in a new tab)

  3. Statistical design of phase I clinical trials

    … designs of Phase I clinical trials, using the continual reassessment method. A parametric model with unknown parameters is assumed. The observations are either toxic or nontoxic. Observations of toxicities are used to update the posterior distribution. Dose selection for the next patient is …

    manitoba Repository record for Statistical design of phase I clinical trials (opens in a new tab)

  4. Bayesian models for discrete censored sampling and dose finding.

    … binomial problems and compare it to non-Bayesian methods. We include examples and a simulation study in which we compare point estimation, interval coverage, and interval width for Bayesian and non-Bayesian methods. The continual reassessment method (CRM) is a Bayesian design often used in Phase I …

    baylor Repository record for Bayesian models for discrete censored sampling and dose finding. (opens in a new tab)

  5. Estensione del Disegno Continual Reassessment Methods (CRM) allo studio di misure ripetute di tossicità in studi Clinici oncologici di fase I .

    A modified version of Continual Reassessment Methods for longitudinal data in Phase I cancer Clinical Trials. Background: In Phase I studies, the Maximum Tolerated Dose (MTD) of a new drugs is determined on the basis of dose limiting toxicities (DLT) observed during the first cycles of treatment. …

    milano Repository record for Estensione del Disegno Continual Reassessment Methods (CRM) allo studio di misure ripetute di tossicità in studi Clinici oncologici di fase I . (opens in a new tab)

  6. Novel statistical designs for phase I clinical trials

    … The commonly used parametric design is the continual reassessment method (CRM). This method assumes a parametric statistical model with unknown parameters to describe toxicity probability at each dose level. These unknown parameters follow prior distributions under the Bayesian approach. …

    manitoba Repository record for Novel statistical designs for phase I clinical trials (opens in a new tab)

  7. Challenges and Opportunities in Glioblastoma and Immunovirotherapy with Oncolytic Herpes Simplex Virus Type 1

    … dose. Dose elevations were made using a modified Continual Reassessment Method with 7 dosing cohorts. Secondary endpoints were (1) to determine a recommended dose level for subsequent trials and (2) to obtain biologic data to optimize future studies. Twenty-one patients with recurrent MG ages 19 …

    uab Repository record for Challenges and Opportunities in Glioblastoma and Immunovirotherapy with Oncolytic Herpes Simplex Virus Type 1 (opens in a new tab)

  8. Bayesian Models for Clinical Trials and Survival Analysis

    In this Thesis, three Bayesian methods are proposed to tackle problems seen in survival analysis and clinical trials. They use Markov Chain Monte Carlo methods (MCMC), reversible jump sampling moves and spike and slab priors. In the first project, Bayesian stochastic search variable selection is …

    rice Repository record for Bayesian Models for Clinical Trials and Survival Analysis (opens in a new tab)

  9. Bivariate Generalization of the Time-to-Event Conditional Reassessment Method with a Novel Adaptive Randomization Method

    … this issue, we generalize the time-to-event continual reassessment method (TITE-CRM) to bivariate outcomes with potentially non-monotonic dose-efficacy relationship. Simulation studies show that the proposed TITE design maintains similar probability in selecting the correct OBD comparing to …

    uky-thes Repository record for Bivariate Generalization of the Time-to-Event Conditional Reassessment Method with a Novel Adaptive Randomization Method (opens in a new tab)

  10. Bayesian Designs For Early Phase Clinical Trials With Novel Target Agents

    … review three model-based designs, including the continual reassessment method (CRM), dose escalation with overdose control (EWOC), and Bayesian logistic regression model (BLRM), and three model-assisted designs, including the modified toxicity probability interval (mTPI), Bayesian optimal …

    uthsc Repository record for Bayesian Designs For Early Phase Clinical Trials With Novel Target Agents (opens in a new tab)

  11. Novel Bayesian Adaptive Clinical Trial Designs In Early Phases

    … rapid accrual. Therefore, dose escalation methods, especially Bayesian designs, are recommended to be used in phase I trials. There are many proposed Bayesian phase I adaptive designs, among them, continual reassessment method (CRM) is the firstly proposed pioneered Bayesian design. The CRM …

    uthsc Repository record for Novel Bayesian Adaptive Clinical Trial Designs In Early Phases (opens in a new tab)